This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Martin Vallés, MD; Carmen Cantarell, MD; Juan Fort, MD; Marta Carrera, MD
Barcelona, Spain

Arch Intern Med. 1982;142(6):1238.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Leprosy is a disease still present in some parts of Spain, where it represents a substantial health problem.

Renal involvement was first described by Mitsuda and Ogawa¹ in 1937, and, since then, numerous patients with amyloidosis and interstitial or glomerular nephropathies have been described, mainly in the lepromatous form of the disease. In recent randomized studies, ten (50%) of 20 patients² and eight (23%) of 35 patients³ with lepromatous leprosy had evidence of proliferative glomerulonephritis.

So far, exudative and proliferative glomerulonephritis, focal proliferative glomerulonephritis, and nonproliferative glomerulonephritis with isolated mesangial sclerosis have been described. In some cases, the histologic study has included immunofluorescent examinations that showed granular deposits of IgG and complement and sometimes IgM. Only one patient had IgA, and, in this case, IgA was not the preponderant immunoglobulin.

In an attempt to contribute further to the spectrum of glomerular pathology associated with . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?